ESC 365 - Glucagon-like peptide 1 receptor agonist use in cardiology.

Open Access

Glucagon-like peptide 1 receptor agonist use in cardiology.

Session: Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Topic: Risk Factors and Prevention

Speaker: Professor M. Petrie (Glasgow, GB)

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Professor Mark Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

47 presentations

8 followers

3 more presentations in this session

Glucagon-like peptide 1 receptor agonists & cardiovascular outcomes: What have we learned?

Speaker: Associate Professor M. Cavender (Chapel Hill, US)

Cardiovascular effects of glucagon-like peptide 1 receptor agonists.

Speaker: Doctor M. Husain (Toronto, CA)

Live panel discussion.

Access the full session

Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Speakers: Professor M. Petrie, Associate Professor M. Cavender, Doctor M. Husain

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources